Oral Short Papers.

Biomarkers of the future in colorectal cancer F. Kamel 1,2, M. Soloviev 2, P. Nisar 1 1 St Peters Hospital, Chertsey, UK; 2 Royal Holloway University of London, Egham, UK B Introduction: b Colorectal cancer (CRC) remains the third most common cause of cancer-related deaths in the United Kingdom. Despite the extensive impact of anal fistula on QoL, there is a lack of patient-centred, disease-specific QoL measurement instruments. B Conclusion: b We have developed an Anal Fistula Quality of Life scale (AF-QoL), a comprehensive, disease-specific patient-reported outcome measure (PROM) assessing QoL in patients with cryptoglandular anal fistula. [Extracted from the article]